Hospital
Chattanooga Hamilton County Hospital Authority
Chattanooga Hamilton County Hospital Authority was paid $52.41M by Medicaid between Jan 2018 and Dec 2024, across 207 billing codes. Its largest line is 99284, emergency room visit (serious) — 27% of everything it billed.
33Billing provider infoCHATTANOOGA HAMILTON COUNTY HOSPITAL AUTHORITY
CHATTANOOGA, TN 37403
CHATTANOOGA, TN 37403
33aNPI1639264575assigned 10/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$52.41M
24GClaims695,671
24DCodes billed207
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#2 of 71
Median peer was paid$6.96M
This provider vs. median7.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 114,241 | $8.63M | |
| 2019 | 113,428 | $7.49M | |
| 2020 | 86,858 | $6.27M | |
| 2021 | 116,856 | $8.90M | |
| 2022 | 140,461 | $10.38M | |
| 2023 | 97,209 | $7.81M | |
| 2024incomplete | 26,618 | $2.92M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 63,935 | 58,548 | $13.95M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 90,102 | 85,859 | $13.56M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 20,559 | 18,326 | $6.20M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.9% | 31,321 | 29,894 | $2.55M |
| 41899 | Unlisted procedure, dentoalveolar structures | 4.0% | 4,510 | 4,432 | $2.08M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 3.4% | 1,755 | 1,647 | $1.79M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.6% | 20,225 | 17,550 | $846K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 8,618 | 8,349 | $681K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.3% | 502 | 477 | $679K |
| G0378 | Hospital observation service, per hour | 1.2% | 1,153 | 1,030 | $634K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.2% | 1,314 | 1,127 | $631K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.1% | 1,614 | 1,549 | $554K |
195 more codes
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 904 | $498K |
| 93304 | <1% | 1,919 | $481K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 16,646 | $435K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 9,983 | $428K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 5,244 | $371K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 45,427 | $344K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,538 | $321K |
| 93325 | <1% | 3,171 | $289K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 8,256 | $253K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 4,343 | $252K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 7,364 | $236K |
| 87076 | <1% | 6,057 | $209K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 9,106 | $197K |
| 80047 | <1% | 19,195 | $194K | |
| 59025 | Fetal non-stress test | <1% | 7,135 | $193K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,596 | $193K |
| 93321 | <1% | 2,396 | $173K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 908 | $165K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 575 | $155K |
| 80053 | Comprehensive metabolic panel | <1% | 21,421 | $148K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 160 | $144K |
| 76770 | <1% | 870 | $137K | |
| 85027 | <1% | 19,329 | $120K | |
| 95812 | <1% | 444 | $118K | |
| 87581 | <1% | 1,621 | $118K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,710 | $118K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 276 | $117K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,478 | $116K |
| 87486 | <1% | 1,621 | $111K | |
| 84484 | <1% | 6,363 | $108K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,480 | $75K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 902 | $67K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 126 | $59K |
| 74018 | <1% | 1,020 | $59K | |
| 52356 | <1% | 29 | $52K | |
| 83690 | <1% | 7,655 | $51K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 100 | $49K |
| 81025 | <1% | 9,150 | $46K | |
| 86141 | <1% | 2,453 | $45K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,432 | $44K |
| 42830 | <1% | 78 | $42K | |
| 81001 | <1% | 23,515 | $39K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 466 | $39K |
| 87430 | <1% | 3,078 | $38K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,302 | $38K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,704 | $35K |
| 74019 | <1% | 1,313 | $34K | |
| 84702 | <1% | 1,634 | $34K | |
| 40830 | <1% | 16 | $34K | |
| 80076 | <1% | 7,900 | $33K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 56 | $32K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,189 | $32K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,099 | $31K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,263 | $31K |
| 72082 | <1% | 250 | $27K | |
| 72081 | <1% | 383 | $22K | |
| 81003 | <1% | 11,865 | $19K | |
| 83735 | <1% | 3,028 | $17K | |
| 77336 | <1% | 369 | $16K | |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 847 | $14K |
| 72170 | <1% | 254 | $14K | |
| 86900 | <1% | 2,327 | $13K | |
| 86850 | <1% | 1,339 | $13K | |
| 87634 | <1% | 293 | $13K | |
| 54161 | <1% | 12 | $13K | |
| 87081 | <1% | 1,269 | $12K | |
| 83605 | <1% | 1,277 | $12K | |
| 73100 | <1% | 203 | $11K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 11,322 | $11K |
| 74246 | <1% | 132 | $11K | |
| 86901 | <1% | 2,300 | $10K | |
| 77077 | <1% | 128 | $10K | |
| C1776 | Joint device (implantable) | <1% | 20 | $8K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $8K |
| 77412 | <1% | 80 | $8K | |
| 83615 | <1% | 1,130 | $8K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 90 | $8K |
| 73130 | <1% | 214 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,953 | $7K |
| 54360 | <1% | 13 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 143 | $6K |
| 82947 | <1% | 748 | $6K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 143 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,754 | $6K |
| 87800 | <1% | 224 | $6K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 12 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,081 | $5K |
| 85730 | <1% | 1,072 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 100 | $5K |
| 93976 | <1% | 45 | $5K | |
| 96367 | <1% | 194 | $5K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 31 | $5K |
| 94010 | <1% | 90 | $5K | |
| 84550 | <1% | 1,016 | $4K | |
| 73610 | <1% | 82 | $4K | |
| 85610 | <1% | 1,166 | $4K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 40 | $4K |
| 82570 | <1% | 911 | $3K | |
| 72100 | <1% | 106 | $3K | |
| 85014 | <1% | 1,549 | $3K | |
| 82731 | <1% | 123 | $3K | |
| C2625 | Stent, non-coronary, temporary, with delivery system | <1% | 47 | $3K |
| 84112 | <1% | 47 | $3K | |
| 85384 | <1% | 412 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 31 | $3K |
| 73630 | <1% | 53 | $3K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 36 | $3K |
| 80061 | Lipid panel | <1% | 465 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 15,858 | $2K |
| 92611 | <1% | 13 | $2K | |
| J3490 | Unclassified drugs | <1% | 17,215 | $2K |
| 85007 | <1% | 1,120 | $2K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 20 | $2K |
| 95806 | <1% | 12 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 29 | $2K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 2,254 | $2K |
| 36416 | <1% | 197 | $2K | |
| 84156 | <1% | 909 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,008 | $1K |
| 74247 | <1% | 13 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 24 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 43 | $1K |
| 87186 | <1% | 225 | $1K | |
| 73090 | <1% | 33 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 193 | $1K |
| 87807 | <1% | 49 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 407 | $1K |
| 87088 | <1% | 231 | $1K | |
| 77072 | <1% | 18 | $923.66 | |
| 82248 | <1% | 59 | $910.19 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 333 | $886.62 |
| J2704 | Injection, propofol, 10 mg | <1% | 17,572 | $869.84 |
| 95816 | <1% | 15 | $841.04 | |
| 69210 | <1% | 24 | $807.80 | |
| 84100 | <1% | 166 | $612.91 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,281 | $577.85 |
| 87040 | <1% | 29 | $576.87 | |
| 80050 | General health panel | <1% | 36 | $576.75 |
| 72110 | <1% | 13 | $573.76 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,254 | $550.48 |
| 96523 | <1% | 52 | $544.91 | |
| 82962 | <1% | 151 | $494.36 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 105 | $441.74 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 437 | $374.49 |
| 73080 | <1% | 12 | $367.68 | |
| 76801 | <1% | 13 | $330.46 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,727 | $318.61 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 15 | $282.27 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,202 | $273.05 |
| 96376 | <1% | 18 | $268.92 | |
| 94729 | <1% | 13 | $232.95 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,618 | $221.84 |
| 82728 | <1% | 64 | $183.62 | |
| 83550 | <1% | 73 | $173.90 | |
| 85652 | <1% | 68 | $171.68 | |
| 87070 | <1% | 282 | $152.86 | |
| 99406 | <1% | 16 | $115.46 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 102 | $110.56 |
| 85045 | <1% | 65 | $105.33 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 474 | $81.81 |
| 82565 | <1% | 17 | $79.76 | |
| 82607 | <1% | 13 | $77.16 | |
| 84439 | <1% | 13 | $74.74 | |
| 87075 | <1% | 132 | $73.56 | |
| 88304 | <1% | 189 | $69.40 | |
| 87205 | <1% | 213 | $67.98 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 145 | $64.23 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 102 | $36.35 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 6,601 | $26.81 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 428 | $17.08 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 46 | $14.97 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 12 | $14.69 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 69 | $2.97 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 15 | $0.06 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 103 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 73 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 250 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 20 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 1,104 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 31 | $0.00 |
| C1769 | Guide wire | 0% | 92 | $0.00 |
| 99308 | Subsequent nursing facility care, per day, straightforward | 0% | 12 | $0.00 |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 0% | 64 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 29 | $0.00 |
| 85018 | 0% | 42 | $0.00 | |
| 88342 | 0% | 13 | $0.00 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 91 | $0.00 |
| J0694 | Injection, cefoxitin sodium, 1 gm | 0% | 54 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 741 | $0.00 |
| C1758 | Catheter, ureteral | 0% | 50 | $0.00 |
| 82365 | 0% | 14 | $0.00 | |
| J2800 | Injection, methocarbamol, up to 10 ml | 0% | 20 | $0.00 |
| 99152 | 0% | 197 | $0.00 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 19 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBREXLER, JAMES (PRESIDENT & CEO)
| Provider | Location | Paid |
|---|---|---|
| Chattanooga Hamilton County Hospital Authority | Pikeville, TN | $5.64M |
| Chattanooga Hamilton County Hospital Authority | Pikeville, TN | $6K |
| Chattanooga Hamilton County Hospital Authority | Chattanooga, TN | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.